HealthEquity Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Revenue	1,291	1,200	999.59	861.75	756.56	733.57
Revenue Growth (YoY)	12.20%	20.03%	16.00%	13.90%	3.13%	37.89%
Cost of Revenue	416.65	422.52	376.95	369.81	331.79	318.24
Gross Profit	874.01	777.26	622.64	491.94	424.77	415.33
Selling, General & Admin	209.78	223	182.93	166.32	144.04	134.46
Research & Development	256.81	239.51	218.81	193.38	157.36	124.81
Amortization of Goodwill & Intangibles	108.01	111.88	92.76	94.59	82.79	76.06
Operating Expenses	574.6	574.39	494.5	454.28	384.2	335.33
Operating Income	299.41	202.87	128.13	37.65	40.57	80
Interest Expense	-59.12	-60.63	-55.46	-48.42	-36.57	-34.88
Interest & Investment Income	11.99	13.91	12.14	1.76	1.5	1.05
Other Non Operating Income (Expenses)	0.08	0.42	0.66	-0.44	1.71	5.08
EBT Excluding Unusual Items	252.37	156.57	85.48	-9.45	7.2	51.25
Merger & Restructuring Charges	-5.88	-40.54	-10.44	-28.65	-75.64	-47.11
Gain (Loss) on Sale of Investments	-	-	-	-	1.69	-
Pretax Income	246.49	116.03	75.04	-38.1	-66.74	4.14
Income Tax Expense	54.67	19.33	19.33	-11.95	-22.45	-4.69
Net Income	191.83	96.7	55.71	-26.14	-44.29	8.83
Net Income to Common	191.83	96.7	55.71	-26.14	-44.29	8.83
Net Income Growth	98.37%	73.58%	-	-	-	-77.73%
Shares Outstanding (Basic)	86	87	86	84	83	74
Shares Outstanding (Diluted)	88	89	87	84	83	76
Shares Change (YoY)	-0.34%	2.15%	2.98%	1.57%	9.85%	10.56%
EPS (Basic)	2.22	1.11	0.65	-0.31	-0.53	0.12
EPS (Diluted)	2.18	1.09	0.64	-0.31	-0.53	0.12
EPS Growth	99.97%	70.31%	-	-	-	-79.48%
Free Cash Flow	412.96	337.77	241.13	147.28	132.09	168.53
Free Cash Flow Per Share	4.68	3.80	2.77	1.74	1.59	2.23
Gross Margin	67.72%	64.78%	62.29%	57.09%	56.15%	56.62%
Operating Margin	23.20%	16.91%	12.82%	4.37%	5.36%	10.91%
Profit Margin	14.86%	8.06%	5.57%	-3.03%	-5.85%	1.20%
Free Cash Flow Margin	32.00%	28.15%	24.12%	17.09%	17.46%	22.97%
EBITDA	454.57	365.32	281.21	198.85	177.76	195.91
EBITDA Margin	35.22%	30.45%	28.13%	23.08%	23.49%	26.71%
D&A For EBITDA	155.16	162.45	153.08	161.2	137.19	115.9
EBIT	299.41	202.87	128.13	37.65	40.57	80
EBIT Margin	23.20%	16.91%	12.82%	4.37%	5.36%	10.91%
Effective Tax Rate	22.18%	16.66%	25.76%	-	-	-
Revenue as Reported	1,291	1,200	999.59	861.75	756.56	733.57

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q